pillbase.ru

Zolgensma

Active substance: onasemnogene abeparvovec

onasemnogene abeparvovec

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Золгенсма®
    раствор для инфузий, 2x10^13 вектор-геномов/мл, 8.3 мл (original in Russian, GRLS)
    ЛП-№(001462)-(РГ-RU)
    Новартис Фарма АГ
  • Золгенсма®
    раствор для инфузий, 2x10^13 вектор-геномов/мл, 8.3 мл (original in Russian, GRLS)
    ЛП-007675
    Новартис Фарма АГ
US 1
  • ITVISMA
    INJECTION, SUSPENSION · ONASEMNOGENE ABEPARVOVEC 40000000000000 [arb'U]/mL
    71894-200
    Novartis Innovative Technologies Inc.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-3f7f-71a4-90df-9e29a94a09b4,01a120c5-33e9-76e3-a57e-195cd9461717;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12090-d2ca-7941-98e8-ffcc8393791e;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004750
Registration status
Active
ATC code
M09AX09
Sources
  • product · EMA · EMEA/H/C/004750 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004750 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004750 · Verified 2026-10-09